Lv51
932 积分 2022-08-03 加入
Cellular and molecular mechanisms determining allogeneic CAR T cell rejection and expansion
3小时前
已完结
Long-Term Follow-Up of Combination of B-Cell Maturation Antigen and CD19 Chimeric Antigen Receptor T Cells in Multiple Myeloma
9天前
已完结
The Virtual Biotech: A multi-agent AI framework for therapeutic discovery and development
10天前
已完结
New insights into progenitor exhausted T cell populations
25天前
已完结
Effector and memory T-cell differentiation: implications for vaccine development
25天前
已完结
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
29天前
已完结
The promises and challenges of neoantigen cancer vaccines
1个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
1个月前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
1个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
1个月前
已完结
皖公网安备34019202002308
